MedscapeLIVE logo

Testing for and Managing COVID-19: Changing with the Times

A 3 Part Series

5:00 pm – 6:00 pm  TZ

CME
swoosh
swoosh

Developed through the strategic collaboration between

 

Webinar 1:

Test-to-Treat: A Stepwise Approach to Identifying Patients at High Risk for Progression to Severe COVID-19

Wednesday, October 26, 2022
12:30 - 1:00 PM ET

As the United States continues year 3 of the COVID-19 pandemic, approximately 50,000 infections are reported weekly -- a number that is believed to be a significant undercount. Prevention efforts with vaccination and non-pharmaceutical interventions continue, and evidence-based management strategies are available. The volume and pace of data on treatments, coupled with the burden of providing patient care during the pandemic, present a significant challenge for clinicians' ability to stay up to date on emerging treatment data and recommendations. Join Dr Ramers in this live-streamed video webcast as he reviews current best practices in testing and management of COVID-19.

 

Webinar 2:

COVID-19: Updates on Treatments for Nonhospitalized Patients

Friday, November 18, 2022
4:30 - 5:00 PM ET

As the United States continues year 3 of the COVID-19 pandemic, approximately 50,000 infections are reported weekly -- a number that is believed to be a significant undercount. For nonhospitalized patients that test positive for SARS-CoV-2 infection, guideline recommended treatments, including antivirals, monoclonal antibodies, and other pharmaceutical agents are available. The volume and pace of data on treatments, coupled with the burden of providing patient care during the pandemic, present a significant challenge for clinicians' ability to stay up to date on emerging treatment data and recommendations. Join Dr Griffin in this live-streamed video webcast as he reviews current best practices in management of COVID-19 in nonhospitalized patients.

 

Webinar 3:

COVID-19 Oral Therapies: Implementing Current Antivirals in Practice

Monday, December 19, 2022
1:00 - 1:30 PM ET

As the United States continues year 3 of the COVID-19 pandemic, approximately 50,000 infections are reported weekly -- a number that is believed to be a significant undercount. For nonhospitalized patients who test positive for SARS-CoV-2 infection, guideline recommended treatments -- including antivirals, monoclonal antibodies, and other pharmaceutical agents -- are available. The volume and pace of data on treatments, coupled with the burden of providing patient care during the pandemic, present a significant challenge for clinicians' ability to stay up to date on emerging treatment data and recommendations. Join Dr Elion in this live-streamed video webcast as he reviews current best practices in implementing oral therapies for COVID-19.

 

TARGET AUDIENCE

Target Audience - Dolor sit amet consectetur adipiscing elit ut

GOAL STATEMENT

Goal Statement - Nibh venenatis cras sed felis eget. In cursus turpis massa tincidunt dui ut ornare.

LEARNING OBJECTIVES

Upon completion of this activity, participants will: Have increased knowledge regarding the [list][item]Learning objective one [item]Learning objective two [/list]Have greater competence related to: [list][item]Learning objective one [item]Learning objective two [/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Medscape, LLC designates this live activity for a maximum [bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

⌃